10X Genomics (TXG) PT Raised to $100 at Cowen After Revenue Beats Despite Research Lab Closures
Tweet Send to a Friend
Cowen analyst Doug Schenkel raised the price target on 10X Genomics (NASDAQ: TXG) to $100.00 (from $90.00) after Q2 revenue ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE